View
2
Download
0
Category
Preview:
Citation preview
Convocatoria 2020 del Reto Social 1
Próxima convocatoria IMI - 2
Juan E. Riese PhD MBAPunto Nacional de Contacto – Reto Social 1 H2020 & IMI2Experto Nacional en el Comité de Programa Reto Social 1Oficina de Proyectos EuropeosSubdirección General de Programas Internacionales de Investigación y Relaciones Institucionales
XXIII Reunión de las CCAA con la SG de Programas Internacionales de Investigación
y Relaciones Institucionales del ISCIII
7 prioridades repartidas en 3 áreas
Area 1. Better health and care, economic growth and sustainable health systems(Topics BHC)
1. Personalised medicine
2. Innovative health and care industry
3. Infectious diseases and improving global health
4. Innovative health and care systems – Integration of care
5. Decoding the role of the environment for health and well-being
Area 2. Digital transformation in health and care (Topics DTH)
Area 3. Trusted digital solutions and cybersecurity in health and care (Topics TDS)
Otras acciones EIC: premios, Instrumento PYME, FTI, FET Open
Fuen
te: C
om
isió
n E
uro
pea
/Dre
amst
ime
Prioridad – Better Health and care, economicgrowth and sustainable health systems (I)
1.1. Personalised Medicine
• SC1-BHC-06-2020: Digital diagnostics – developing tools for supportingclinical decisions by integrating various diagnostic data (10-15M€; 3-4projects – total 40M€)
• SC1-HCO-01-2018/19/20: Actions in support of the InternationalConsortium for Personalised Medicine (1-2M€; 2-4 projects – total 4M€)
• SC1-HCO-03-2020: Bridging the divide in health research and innovation –boosting return on investment (1-2M€; 1-2 projects – total 2M€)
• SC1-HCO-14-2020: Sustained collaboration of national and regionalprogrammes in cancer research (1-5M€; 1-5 projects – total 5M€)
• SC1-HCO-16-2020: Sustained collaboration of national and regionalprogrammes in research on brain-related diseases and disorders of thenervous system (1-5M€; 1-5 projects – total 5M€)
• SC1-HCO-17-2020: Coordinating and supporting research on the humanmicrobiome in Europe and beyond (1-2M€; 1-2 projects – total 2M€)
Prioridad – Better Health and care, economicgrowth and sustainable health systems (II)
1.2. Innovative health and care industry
• SC1-BHC-08-2020: New interventions for Non-Communicable Diseases (4-6M€; 14-20 projects – total 80 M€)
• SC1-BHC-11-2020: Advancing the safety assessment of chemicals without the use of animal testing (10-20M€; 3-6 projects – total 60 M€)
• SC1-HCO-18-2020: Developing methodological approaches for improved clinical investigation and evaluation of high-risk medical devices (1-2M€; 1-2 projects –total 2 M€)
• SC1-HCO-19-2020: Reliable and accessible information on cell and gene-based therapies (1-2M€; 1-2 projects – total 2 M€)
1.3 Infectious diseases and improving global health
• SC1-BHC-17-2020: Global Alliance for Chronic Diseases (GACD) - Prevention and/or early diagnosis of cancer (1-3M€; 7-20 projects – total 20 M€)
• SC1-BHC-20A-2020: Pre-commercial procurement (PCP) for integrated care solutions (5-6M€; 4-5 projects – total 25 M€)
• SC1-BHC-20B-2020: Public procurement of innovative solutions (PPI) for diagnostics for infectious diseases (3-5M€; 5-8 projects – total 25 M€ Fu
ente
: Co
mis
ión
Eu
rop
ea
Prioridad – Better Health and care, economicgrowth and sustainable health systems (III)
1.3 Infectious diseases and improving global health (cont.)
• SC1-BHC-33-2020: Addressing low vaccine uptake (2-3M€; 3-4 projects –total 9 M€)
• SC1-BHC-34-2020: New approaches for clinical management and prevention of resistant bacterial infections in high prevalence settings (15M€; 1-2 projects – total 25 M€)
• SC1-BHC-35-2020: Creation of a European wide sustainable network for harmonised large-scale clinical research studies for infectious diseases (25-30M€; 1-2 projects – total 30 M€)
• SC1-HCO-07-2020: to support the Joint Programming Initiative on Antimicrobial resistance (JPIAMR) (1-5M€; 1-2 projects – total 5 M€)
Fuen
te: C
om
isió
n E
uro
pea
Prioridad – Better Health and care, economicgrowth and sustainable health systems (IV)
1.4. Innovative health and care systems - Integration of care
• SC1-BHC-24-2020: Healthcare interventions for the management of the elderly multimorbid patient (4-6M€; 8-12 projects – total 50 M€)
• SC1-BHC-37-2020: Towards the new generation of clinical trials – trials methodology research (4-6M€; 1-2 projects – total 6 M€) Lump sum
• SC1-HCO-20-2020: Coordination of clinical research activities of the European Reference Networks (1-2M€; 1-2 projects – total 2 M€)
1.5 Decoding the role of the environment for health and well-being
• SC1-BHC-29-2020: Innovative actions for improving urban health and wellbeing - addressing environment, climate and socioeconomic factors (4-5 M€; 7-9 projects – total 35 M€)
• SC1-BHC-36-2020: Micro- and nano-plastics in our environment: Understanding exposures and impacts on human health (4-6M€; 4-6 projects – total 25 M€)
Fuen
te: C
om
isió
n E
uro
pea
Prioridad – Better Health and care, economicgrowth and sustainable health systems (y V)
1.6 Contribution to the Call on Digital transformation in Health and Care
• SC1-DTH-12-2020: Use of Real-World Data to advance research on the management of complex chronic conditions (4-6M€; 7-10 projects – total 41 M€)
• SC1-DTH-13-2020: Implementation research for scaling up and transfer of innovative solutions involving digital tools for people-centred care (3-4M€; 5-6 projects – total 20 M€)
• SC1-HCC-10-2020: Towards a Health research and innovation Cloud: Capitalising on data sharing initiatives in health research (2-3M€; 1-2 projects – total 3 M€)
Fuen
te: C
om
isió
n E
uro
pea
Prioridad – Digital transformation in Health and Care
• SC1-DTH-02-2020: Personalised early risk prediction, prevention and intervention based on Artificial Intelligence and Big Data technologies (4-6M€; 5-8 projects – total 32M€)
• SC1-DTH-04-2020: International cooperation in smart living environments for ageing people (2-4M€; 2-4 projects – total 8M€)
• SC1-DTH-06-2020: Accelerating the uptake of computer simulations for testing medicines and medical devices (6-8M€; 4-5 projects – total 32M€)
• SC1-DTH-14-2020: Pre-commercial Procurement for Digital Health and Care Solutions (5-6M€; 1-2 projects – total 10M€) – (Este Topic sustituye al DTH-10 previsto inicialmente)
• SC1-HCC-06-2020: Coordination and Support to better data and secure cross-border digital infrastructures building on European capacities for genomics and personalised medicine (4M€; 1-4 projects – total 4M€)
• SC1-HCC-07-2020: Support for European eHealth Interoperability roadmap for deployment (1-2M€; 1-2 projects – total 2M€)
• SC1-HCC-08-2020: Scaling up innovation for active and healthy ageing (1-2M€; 1-2 projects – total 2M€)
• SC1-HCC-09-2020: Supporting deployment of eHealth in low and lower middle income countries in Africa for better health outcomes (1-2M€; 1-2 projects – total 2 M€)
En todos los topics DTH se exigen indicadores apropiados para la medida del progreso e impacto del proyecto.
Fuen
te: C
om
isió
n E
uro
pea
Prioridad – Trusted Digital Solutions and Cybersecurity in Health and Care
• DT-TDS-04-2020: AI for Genomics and Personalised Medicine (10M€; 3-4 projects –total 35M€)
• DT-TDS-05-2020: AI for Health Imaging (8-10 M€; 3-5 projects – total 35M€) (focused on the most common types of cancer)
Fuen
te: C
om
isió
n E
uro
pea
/PD
F Fi
ller/
Dr
Wae
lHas
san
Presupuesto total para las convocatorias del SC1
• Call SC1 2018: 650,99 M€
• Call SC1 2019: 787,18 M€
• Call SC1 2020: 783,92 M€
0
100
200
300
400
500
600
700
800
900
2018 2019 2020
Tabla de fechas convocatoria 2020 del SC1
Topics Apertura Cierre Observaciones
SC1-BHC-37-2020 04.07.2019 07.04.2020 RIA-LS
SC1-BHC-06/11/17/20A/20B/33/34/35/36 04.07.2019 07.04.2020 RIA
SC1-BHC-8/24/29 04.07.20191st-24.09.20192nd-07.04.2020
RIA
SC1-DTH-12 04.07.2019 07.04.2020 RIA
SC1-DTH-13 04.07.20191st-24.09.20192nd-07.04.2020
RIA
SC1-HCC-10 04.07.2019 07.04.2020 CSA
SC1-HCO-1/3/7/14/16 a 20 04.07.2019 07.04.2020 ERA-NET/CSA
SC1-DTH-2/4/6/14 19.11.2019 22.04.2020 RIA/PCP
SC1-HCC-6 09.07.2019 13.11.2019 CSA
SC1-HCC-7/8/9 19.11.2019 22.04.2020 CSA
SC1-TDS-5 09.07.2019 13.11.2019 RIA
SC1-TDS-4 19.11.2019 22.04.2020 RIA
Fuen
te: C
om
isió
n E
uro
pea
/12
3rf
La Iniciativa de
Medicamentos Innovadores 2
(IMI 2)http://www.imi.europa.eu/
Fuen
te: I
MI
Funcionamiento de la IMI 2
Fuen
te: I
MI
Las convocatorias IMI 2
Fuen
te: I
MI
1. Central repository of digital pathology slidesto support the development of artificialintelligence tools
2. Health Outcomes Observatories – empowerpatients with tools to measure theiroutcomes in a standardised manner creatingtransparency of health outcomes
3. Improving patient access, understanding andadherence to healthcare information: anintegrated digital health information project
4. Establishing international standards in theanalysis of patient reported outcomes andhealth-related quality of life data in cancerclinical trials
5. Accelerating research & development foradvanced therapy medicinal products
6. Supporting the development of chimericantigen receptor T cells
2-stages Topics previstos en las convocatorias 18ª/19ª
¡Provisionales! Comprobar en:https://www.imi.europa.eu/apply-funding/future-topics
Calls Publication Date: 26 June 2019
Stage 1 deadline: 26 September 2019
Stage 2 deadline: 26 March 2020
Call Identifier: H2020-JTI-IMI2-2019-18-two-stage
Type of Actions: Research and Innovation (RIA)
Fuen
te: C
om
isió
n E
uro
pea
Restricted call to maximise impact of IMI2 JUobjectives and scientific priorities
1-stage Topic previsto en las convocatorias 18/19ª
¡Provisional! Comprobar en:https://www.imi.europa.eu/apply-funding/future-topics
Call Publication Date: 26 June 2019
Submission deadline: 26 September 2019
Call Identifier: H2020-JTI-IMI2-2019-19-single-stage
Type of Actions: Research and Innovation (RIA)
Fuen
tes:
Co
mis
ión
Eu
rop
ea/V
idas
enci
lla
Neurodegeneration and other neuroscience priorities
Digital transformation of clinical trial endpoints in pain
Placebo effect in pain
Psychiatric ratings using intermediate stratified markers -2 (PRISM-2)
Immunology
Psoriatic arthritis
Infection control including vaccines
New topic(s) under the AMR accelerator platform
Translational safety
Dosing in specific populations
Big data, digital health, clinical trials and regulatory research
ROADMAP 2: need and opportunity for public-private collaborative research to continue the RoadMap efforts
Facilitating the translation of advanced therapies to patients in Europe
ATMP Patient Registries Outcomes Data and Evidence
Innovative Manufacturing of Advanced Therapeutic Medicinal Products, ATMPs
Other enablers of research topics
Handling of biologic drug products
Potential future IMI Call topics
Last updated April, 2019
Fuen
te: C
om
isió
n E
uro
pea
Las oportunidades en el European Innovation Council (EIC)
Fuen
te: C
om
isió
n E
uro
pea
€1028 millions for 2019€1228 millions for 2020
Más información: https://ec.europa.eu/research/eic/index.cfm?pg=funding
Resumen oportunidades en el European Innovation Council (EIC)
Fuen
te: C
om
isió
n E
uro
pea
Más información: https://ec.europa.eu/research/eic/index.cfm
Recommended